Condition

Acute Myeloid Leukemia With KMT2A Rearrangement clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Combination treatment for relapsed or refractory acute myeloid leukemia with specific mutations

  This study is testing a new combination of two drugs for people with relapsed or hard-to-treat acute myeloid leukemia that has specific gene mutations to see if it helps them feel better.

  Recruiting at 4 sites Phase 1 Ohio State University Comprehensive Cancer Center · Chapel Hill, North Carolina and 3 other locations · NCT06222580

• Combining SNDX-5613 with standard chemotherapy for newly diagnosed acute myeloid leukemia

  This study is testing a new drug called SNDX-5613 combined with standard chemotherapy to see if it can improve treatment for people with newly diagnosed acute myeloid leukemia that has certain genetic mutations.

  Recruiting at 21 sites Phase 1 National Cancer Institute (NCI) · Orange, California and 22 other locations · NCT05886049

Related topics

Quick answers

How many Acute Myeloid Leukemia With KMT2A Rearrangement clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →